Energy Production and Metabolism — MCQs

Energy Production and Metabolism Indian Medical PG Practice Questions and MCQs

Question 161: Number of ATP molecules produced from adipose tissue from 1 NADH (NAD+/NADH) through the respiratory chain?

A. 0 ATP
B. 1 ATP
C. 2 ATP
D. 2.6 ATP (Correct Answer)

Explanation: ### Explanation The correct answer is **2.6 ATP** (Option D). **1. Why 2.6 ATP is correct:** In modern biochemistry (based on the P/O ratio), the oxidation of one molecule of mitochondrial **NADH** yields approximately **2.5 to 2.6 ATP**. This value is derived from the chemiosmotic theory: the transport of electrons from NADH to Oxygen pumps **10 protons ($H^+$)** across the inner mitochondrial membrane. Since it takes approximately 4 protons to synthesize and export 1 ATP (3 for the ATP synthase rotor and 1 for phosphate transport), the calculation is $10/4 = 2.5$. In many standardized exams like NEET-PG, the value **2.6** is often cited as the precise yield for NADH. **2. Why the other options are incorrect:** * **A (0 ATP):** Incorrect. NADH is the primary electron donor to the Electron Transport Chain (ETC); its oxidation is the main driver of ATP production. * **B (1 ATP):** Incorrect. This value does not correspond to any standard electron carrier. * **C (2 ATP):** Incorrect. This is closer to the yield of **$FADH_2$** (which yields ~1.5 to 1.6 ATP). Historically, older textbooks used integers (3 ATP for NADH, 2 ATP for $FADH_2$), but these have been replaced by the more accurate decimal values. **3. Clinical Pearls & High-Yield Facts:** * **P/O Ratio:** Refers to the number of inorganic phosphates incorporated into ATP per atom of oxygen consumed. * **Shuttle Systems:** While NADH produced *inside* the mitochondria yields 2.5–2.6 ATP, **cytosolic NADH** (from glycolysis) must use shuttles: * **Malate-Aspartate Shuttle:** Yields ~2.5 ATP (predominant in heart, liver, and kidney). * **Glycerol-3-Phosphate Shuttle:** Yields ~1.5 ATP (predominant in muscle and brain). * **Uncouplers:** Substances like **2,4-DNP** or **Thermogenin** (found in brown adipose tissue) dissipate the proton gradient, allowing NADH oxidation to continue without producing ATP, instead releasing energy as heat.

Question 162: In the TCA cycle, NADH is produced at all sites except which of the following?

A. Isocitrate dehydrogenase
B. Succinate dehydrogenase (Correct Answer)
C. Malate dehydrogenase
D. Pyruvate dehydrogenase

Explanation: ### Explanation The Citric Acid Cycle (TCA cycle) is the central metabolic pathway for energy production. In this cycle, three molecules of **NADH** and one molecule of **FADH₂** are produced per turn. **Why Succinate Dehydrogenase is the correct answer:** The enzyme **Succinate Dehydrogenase (SDH)** catalyzes the conversion of Succinate to Fumarate. Unlike other dehydrogenases in the cycle, SDH uses **FAD** as an electron acceptor instead of NAD⁺, resulting in the production of **FADH₂**. * **Unique Fact:** SDH is the only enzyme of the TCA cycle that is embedded in the inner mitochondrial membrane (forming **Complex II** of the Electron Transport Chain), whereas all other enzymes are located in the mitochondrial matrix. **Analysis of Incorrect Options:** * **Isocitrate Dehydrogenase (A):** This is the rate-limiting step of the TCA cycle. It catalyzes the oxidative decarboxylation of Isocitrate to α-Ketoglutarate, producing the **first molecule of NADH** and CO₂. * **Malate Dehydrogenase (C):** This enzyme catalyzes the final step of the cycle (Malate to Oxaloacetate), producing the **third molecule of NADH**. * **Pyruvate Dehydrogenase (D):** While technically part of the "Link Reaction" (connecting glycolysis to the TCA cycle), the PDH complex produces **NADH** during the conversion of Pyruvate to Acetyl-CoA. **High-Yield Clinical Pearls for NEET-PG:** * **NADH Producing Steps:** Isocitrate dehydrogenase, α-Ketoglutarate dehydrogenase, and Malate dehydrogenase. * **FADH₂ Producing Step:** Succinate dehydrogenase. * **Substrate Level Phosphorylation (GTP):** Occurs at the step catalyzed by **Succinate Thiokinase** (Succinyl-CoA to Succinate). * **Inhibitor:** Malonate is a competitive inhibitor of Succinate Dehydrogenase (structurally similar to Succinate).

Question 163: Which of the following is true for the Creatine-Phosphate Shuttle?

A. Transports ATP from mitochondria to cytoplasm (Correct Answer)
B. Transports Acetyl CoA from mitochondria to cytoplasm
C. Takes NADH from cytoplasm and delivers NADH into the mitochondria
D. Takes NADH from cytoplasm and delivers FADH2 into the mitochondria

Explanation: ### Explanation: The Creatine-Phosphate Shuttle The **Creatine-Phosphate (CrP) Shuttle** is a vital mechanism for high-energy phosphate transport in tissues with high and fluctuating energy demands, such as skeletal muscle, cardiac muscle, and the brain. **1. Why Option A is Correct:** While ATP is produced in the mitochondrial matrix via oxidative phosphorylation, it cannot diffuse rapidly enough to meet the demands of myofibrils or ion pumps in the cytoplasm. In the shuttle: * **Mitochondrial Creatine Kinase (mCK)** converts Creatine and mitochondrial ATP into **Phosphocreatine (PCr)** and ADP. * PCr, being a smaller and less polar molecule than ATP, diffuses rapidly into the cytoplasm. * **Cytoplasmic Creatine Kinase (cCK)** then reverses the reaction, transferring the phosphate from PCr to ADP, regenerating **ATP** exactly where it is needed for contraction. Thus, it effectively "transports" the high-energy bond of ATP from the mitochondria to the cytoplasm. **2. Why Other Options are Incorrect:** * **Option B:** Acetyl CoA is transported from the mitochondria to the cytoplasm via the **Citrate Shuttle** (where it is converted to citrate first) for fatty acid synthesis. * **Option C:** This describes the **Malate-Aspartate Shuttle**, which moves reducing equivalents (NADH) into the mitochondria without loss of energy (yielding ~2.5 ATP). * **Option D:** This describes the **Glycerol-3-Phosphate Shuttle**, which delivers electrons from cytoplasmic NADH to mitochondrial FADH2 (yielding ~1.5 ATP). **3. Clinical Pearls & High-Yield Facts:** * **CK-MB Isoenzyme:** Clinical marker for myocardial infarction; it reflects the heart's reliance on this shuttle. * **Creatine Supplementation:** Used by athletes to increase the pool of PCr, enhancing the short-term "buffer" for ATP during high-intensity bursts. * **Energy Buffer:** The shuttle acts as a "spatial and temporal buffer," maintaining a constant ATP/ADP ratio at the site of utilization.

Question 164: Which of the following is NOT a rate-limiting enzyme of the TCA cycle?

A. Citrate synthase
B. Alpha-ketoglutarate dehydrogenase
C. Isocitrate dehydrogenase
D. Succinate dehydrogenase (Correct Answer)

Explanation: **Explanation:** The TCA cycle (Krebs cycle) is regulated primarily at three highly exergonic, irreversible steps. These steps serve as the "checkpoints" or rate-limiting stages of the cycle. **Why Succinate Dehydrogenase is the correct answer:** Succinate dehydrogenase (Complex II) catalyzes the conversion of succinate to fumarate. Unlike the rate-limiting enzymes, this reaction is **reversible** and has a Gibbs free energy change ($\Delta G$) near zero. Furthermore, it is the only enzyme of the TCA cycle that is embedded in the inner mitochondrial membrane as part of the Electron Transport Chain (ETC). It is regulated by substrate availability rather than allosteric control, making it a non-regulatory step in the cycle. **Analysis of Incorrect Options:** * **Isocitrate Dehydrogenase:** This is the **primary/major rate-limiting enzyme** of the TCA cycle. it is strongly inhibited by ATP and NADH and activated by ADP and $Ca^{2+}$. * **Alpha-ketoglutarate Dehydrogenase:** This enzyme complex catalyzes a key irreversible oxidative decarboxylation. It is inhibited by its products (Succinyl CoA and NADH) and is a major site of control. * **Citrate Synthase:** This is the first committed step of the cycle. It is regulated by substrate availability (Oxaloacetate) and inhibited by Citrate and ATP. **High-Yield Clinical Pearls for NEET-PG:** * **Major Rate-Limiting Step:** Isocitrate Dehydrogenase. * **Cofactors for $\alpha$-KGDH:** Requires five cofactors (The **T**ender **L**oving **C**are **F**or **N**ancy): **T**hiamine (B1), **L**ipoic acid, **C**oA (B5), **F**AD (B2), and **N**AD (B3). * **Inhibitor of Succinate Dehydrogenase:** **Malonate** (a classic example of competitive inhibition). * **Fluoroacetate:** Inhibits Aconitase ("Suicide inhibition").

Question 165: Carbon monoxide (CO) binds with which complex of the electron transport chain?

A. Complex I
B. Complex II
C. Complex III
D. Complex IV (Correct Answer)

Explanation: **Explanation:** The correct answer is **Complex IV (Cytochrome c Oxidase)**. The Electron Transport Chain (ETC) consists of a series of protein complexes that transfer electrons to generate a proton gradient. **Complex IV** contains two heme groups ($a$ and $a_3$) and two copper centers. **Carbon Monoxide (CO)**, along with Cyanide ($CN^-$) and Azide ($N_3^-$), binds specifically to the **ferrous ($Fe^{2+}$) state of Cytochrome $a_3$**. This binding inhibits the final step of the ETC—the transfer of electrons to molecular oxygen—effectively halting ATP production and causing cellular hypoxia. **Why other options are incorrect:** * **Complex I (NADH Dehydrogenase):** Inhibited by **Rotenone**, Amobarbital (Amytal), and Piericidin A. * **Complex II (Succinate Dehydrogenase):** Inhibited by **Malonate** (a competitive inhibitor of succinate) and Carboxin. * **Complex III (Cytochrome $bc_1$ complex):** Inhibited by **Antimycin A** and British Anti-Lewisite (BAL). **High-Yield Clinical Pearls for NEET-PG:** * **CO Poisoning Mechanism:** CO has a dual toxic effect. It inhibits Complex IV and also binds to Hemoglobin with 200–250x higher affinity than Oxygen, shifting the oxygen-dissociation curve to the **left** (decreasing $O_2$ unloading to tissues). * **Antidote:** 100% Hyperbaric Oxygen (helps displace CO from hemoglobin and cytochrome $a_3$). * **Classic Sign:** "Cherry-red" skin discoloration (though often a post-mortem finding). * **Complex V Inhibitor:** Oligomycin (inhibits the $F_0$ fraction of ATP synthase).

Question 166: Reactive oxygen intermediates are released by which enzyme?

A. Catalase
B. NADPH oxidase (Correct Answer)
C. Glutathione peroxidase
D. Superoxide dismutase

Explanation: ### Explanation The correct answer is **NADPH oxidase**. **1. Why NADPH Oxidase is Correct:** NADPH oxidase (nicotinamide adenine dinucleotide phosphate oxidase) is the key enzyme responsible for the **Respiratory Burst** in phagocytes (neutrophils and macrophages). It catalyzes the transfer of an electron from NADPH to molecular oxygen ($O_2$), resulting in the production of the **Superoxide anion ($O_2^{•-}$)**, a potent reactive oxygen intermediate (ROI). This process is essential for the oxygen-dependent killing of ingested microorganisms. **2. Why the Other Options are Incorrect:** * **Superoxide Dismutase (SOD):** This enzyme actually **neutralizes** ROIs. It converts the superoxide radical into hydrogen peroxide ($H_2O_2$) and oxygen. * **Catalase:** This is an antioxidant enzyme found in peroxisomes. It breaks down hydrogen peroxide into water and oxygen, thereby **preventing** oxidative damage. * **Glutathione Peroxidase:** This enzyme reduces hydrogen peroxide to water (and lipid hydroperoxides to alcohols) using reduced glutathione as an electron donor. It is a **protective** mechanism against oxidative stress. **3. High-Yield Clinical Pearls for NEET-PG:** * **Chronic Granulomatous Disease (CGD):** A deficiency in **NADPH oxidase** leads to CGD. Patients suffer from recurrent infections with **catalase-positive organisms** (e.g., *S. aureus*, *Aspergillus*) because they cannot produce their own ROIs to kill them. * **Nitroblue Tetrazolium (NBT) Test:** Historically used to diagnose CGD; a positive test (blue color) indicates normal NADPH oxidase activity. * **MPO (Myeloperoxidase):** This enzyme uses the $H_2O_2$ produced by SOD to create **Hypochlorous acid (HOCl)**, the most potent bactericidal agent in neutrophils.

Question 167: High energy phosphates are produced in the following metabolic pathways, except?

A. Pentose Phosphate Pathway (Correct Answer)
B. Oxidative Phosphorylation
C. Glycolysis
D. Tricarboxylic Acid Cycle

Explanation: **Explanation:** The primary goal of cellular metabolism is the generation of **High Energy Phosphates (ATP/GTP)**. The correct answer is **Pentose Phosphate Pathway (PPP)**, also known as the Hexose Monophosphate (HMP) Shunt. **1. Why Pentose Phosphate Pathway is the correct answer:** Unlike other metabolic pathways, the PPP does **not** produce or consume ATP directly. Instead, its primary functions are the generation of **NADPH** (used for reductive biosynthesis and maintaining reduced glutathione) and **Ribose-5-phosphate** (for nucleotide synthesis). Since no high-energy phosphate bonds are generated, it is the "exception" in this list. **2. Why the other options are incorrect:** * **Oxidative Phosphorylation:** This is the major site of ATP production in aerobic organisms. It generates the bulk of cellular ATP via the Electron Transport Chain (ETC) and ATP synthase. * **Glycolysis:** Produces a net gain of **2 ATP** per glucose molecule through substrate-level phosphorylation (specifically at the steps catalyzed by Phosphoglycerate kinase and Pyruvate kinase). * **Tricarboxylic Acid (TCA) Cycle:** Produces **1 GTP** (equivalent to ATP) per turn via substrate-level phosphorylation at the Succinate thiokinase (Succinyl-CoA synthetase) step. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme of PPP:** Glucose-6-Phosphate Dehydrogenase (G6PD). * **G6PD Deficiency:** Leads to hemolytic anemia because the cell cannot produce enough NADPH to keep glutathione reduced, making RBCs susceptible to oxidative stress (Heinz bodies). * **Substrate-level phosphorylation:** Remember the specific enzymes in Glycolysis and TCA cycle that produce ATP/GTP directly without the ETC; these are frequent exam targets.

Question 168: Which of the following describes the role of coenzyme Q (ubiquinone) in the respiratory chain?

A. It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential. (Correct Answer)
B. It links NAD-dependent dehydrogenases to cytochrome b.
C. It links each of the cytochromes in the respiratory chain to one another.
D. It is the first step in the respiratory chain.

Explanation: **Explanation:** Coenzyme Q (Ubiquinone) is a unique, lipid-soluble mobile electron carrier located within the inner mitochondrial membrane. Its primary role is to collect reducing equivalents from various flavoproteins and transfer them to the cytochrome system. **Why Option A is Correct:** Ubiquinone acts as a "collector" of electrons. It receives electrons from **Complex I** (via FMN) and **Complex II** (via FAD/Succinate dehydrogenase). These are both flavoprotein-linked complexes. From here, Ubiquinone transfers electrons to **Cytochrome b**, which is the first component of Complex III. Among the cytochromes, Cytochrome b has the **lowest redox potential** (approximately +0.07 V), allowing electrons to flow spontaneously toward cytochromes with higher potentials (c1, c, a, and a3). **Analysis of Incorrect Options:** * **Option B:** Ubiquinone does not link NAD-dependent dehydrogenases *directly* to cytochrome b. Electrons from NADH must first pass through the flavoprotein **FMN** (Complex I) before reaching Ubiquinone. * **Option C:** Ubiquinone does not link all cytochromes. It specifically shuttles electrons to Complex III. Other carriers, like the peripheral protein **Cytochrome c**, link Complex III to Complex IV. * **Option D:** The first step is the oxidation of NADH by Complex I or Succinate by Complex II; Ubiquinone is an intermediate carrier. **High-Yield Clinical Pearls for NEET-PG:** * **Nature:** It is the only non-protein component of the Electron Transport Chain (ETC). * **Structure:** It contains a long isoprenoid side chain (10 units in humans, hence CoQ10), making it highly lipophilic. * **Function:** It participates in the **Q-cycle**, which is essential for proton pumping at Complex III. * **Inhibitors:** Drugs like **Statins** inhibit HMG-CoA reductase, which can decrease CoQ10 synthesis (as both share the mevalonate pathway), potentially leading to muscle toxicity (myopathy).

Question 169: Which of the following inhibits the citric acid cycle?

A. Fluoroacetate (Correct Answer)
B. Fluorouracil
C. Arsenic
D. Aerobic conditions

Explanation: **Explanation:** The citric acid cycle (TCA cycle) is inhibited by **Fluoroacetate**, a potent metabolic poison. Fluoroacetate itself is not the inhibitor; it undergoes "lethal synthesis" by reacting with Coenzyme A to form fluoroacetyl-CoA, which then condenses with oxaloacetate to form **fluorocitrate**. Fluorocitrate is a competitive inhibitor of the enzyme **Aconitase**, effectively halting the cycle and leading to the accumulation of citrate. **Analysis of Options:** * **A. Fluoroacetate (Correct):** Inhibits Aconitase via fluorocitrate formation. * **B. Fluorouracil (5-FU):** This is a pyrimidine analog used in cancer chemotherapy. It inhibits **Thymidylate Synthase**, affecting DNA synthesis, not the TCA cycle. * **C. Arsenic:** While trivalent arsenic (Arsenite) inhibits the **Pyruvate Dehydrogenase (PDH) complex** and **$\alpha$-ketoglutarate dehydrogenase** (by binding to lipoic acid), the question specifically focuses on the TCA cycle's classic inhibitors. Fluoroacetate is the most direct inhibitor of a cycle-specific enzyme (Aconitase). * **D. Aerobic conditions:** The TCA cycle is an aerobic process. It requires oxygen indirectly to regenerate $NAD^+$ and $FAD$ via the electron transport chain. Therefore, aerobic conditions promote, rather than inhibit, the cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Lethal Synthesis:** A process where an enzyme converts a non-toxic substance into a toxic one (e.g., Fluoroacetate $\rightarrow$ Fluorocitrate). * **Other TCA Inhibitors:** Malonate is a competitive inhibitor of **Succinate Dehydrogenase** (structurally similar to succinate). * **Arsenic Poisoning:** Look for symptoms like "rice-water stools," garlic breath, and Mees' lines on nails. It inhibits enzymes requiring **Lipoic acid** as a cofactor.

Question 170: Which of the following is a mobile component of the electron transporting respiratory chain?

A. Flavoprotein
B. Cytochrome C1
C. Ubiquinone (Correct Answer)
D. Cytochrome A

Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of five complexes located in the inner mitochondrial membrane. While most components are integral membrane proteins fixed within the lipid bilayer, two components are **mobile carriers** that shuttle electrons between these complexes: **Ubiquinone (Coenzyme Q)** and **Cytochrome c**. **Why Ubiquinone is correct:** Ubiquinone (Coenzyme Q) is a lipid-soluble, non-protein molecule. Due to its hydrophobic nature, it can diffuse freely within the lipid bilayer of the inner mitochondrial membrane. It functions as a mobile collector, picking up electrons from both Complex I (NADH dehydrogenase) and Complex II (Succinate dehydrogenase) and delivering them to Complex III. **Why other options are incorrect:** * **Flavoprotein (Option A):** These are prosthetic groups (like FMN or FAD) tightly bound to the protein subunits of Complex I and Complex II. They are not mobile. * **Cytochrome c1 (Option B):** This is a fixed component of the cytochrome $bc_1$ complex (Complex III). It should not be confused with **Cytochrome c**, which is a peripheral membrane protein and a mobile carrier. * **Cytochrome a (Option D):** This is a fixed component of Complex IV (Cytochrome c oxidase), along with Cytochrome $a_3$ and copper centers. **High-Yield Clinical Pearls for NEET-PG:** * **Two Mobile Carriers:** Remember **Ubiquinone** (lipid-soluble, moves within the membrane) and **Cytochrome c** (water-soluble, moves along the outer surface of the inner membrane). * **Inhibitors:** Rotenone inhibits Complex I; Antimycin A inhibits Complex III; Cyanide, CO, and Azide inhibit Complex IV. * **Coenzyme Q10:** Clinically used as an antioxidant and in the management of mitochondrial myopathies and statin-induced myalgia.

Practice by Chapter

Bioenergetics and Thermodynamics

Practice Questions

ATP as Energy Currency

Practice Questions

Tricarboxylic Acid Cycle

Practice Questions

Electron Transport Chain

Practice Questions

Oxidative Phosphorylation

Practice Questions

Mitochondrial Diseases

Practice Questions

Uncouplers and Inhibitors of Oxidative Phosphorylation

Practice Questions

Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate

Practice Questions

Energy Yield from Nutrients

Practice Questions

Metabolic Rate and Basal Metabolism

Practice Questions

Brown Adipose Tissue and Thermogenesis

Practice Questions

Oxygen Toxicity and Free Radicals

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free